Post-hepatectomy haemorrhage: a single-centre experience  by Li, Aijun et al.
ORIGINAL ARTICLE
Post-hepatectomy haemorrhage: a single-centre experience
Aijun Li*, Bin Wu*, Weiping Zhou, Weifeng Yu, Li Li, Hang Yuan & Mengchao Wu
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China
Abstract
Objectives: This study aimed to explore the incidence and causes of intra-abdominal haemorrhage after
hepatectomy, indications for re-exploration, and factors affecting occurrence.
Methods: Clinical data for 77 patients (0.2% of 32 856 hepatectomy patients) submitted to
re-exploration for haemorrhage following hepatectomy for primary liver cancer (PLC) from 2001 to 2010
were retrospectively reviewed and analysed for postoperative complications, potential site and cause of
bleeding.
Results: The median interval between hepatectomy and re-exploration was 23 h in the 77 patients
(range: 1 h to 11 days). Re-exploration occurred within 24 h after hepatectomy in 64 patients (83.1%), and
within 8 h in 37 patients (48.1%). The most common anatomic site of intra-abdominal haemorrhage was
the cut surface of the liver (n = 51, 66.2%), followed by the perihepatic ligaments (n = 19, 24.7%), the
splenic fossa (n = 7, 9.1%), the diaphragm (n = 6, 7.8%), the retroperitonium (n = 6, 7.8%), the right
adrenal gland (n = 3, 3.9%), and the gallbladder bed (n = 2, 2.6%). The most common form of bleeding
was oozing. Early haemorrhage (at ≤ 24 h) was most likely to occur in the form of venous bleeding or
oozing from the cut surface of the liver. Rates of 5-year overall and disease-free survival in the 77 patients
were 22.1% and 3.9%, respectively.
Conclusions: Re-exploration for haemorrhage following hepatectomy for PLC is a rare event. Haem-
orrhage occurs predominantly at the cut parenchymal surface. Early return to the operating room is vital
and perioperative survival is common in this high-risk group.
Received 10 July 2013; accepted 14 February 2014
Correspondence
Mengchao Wu, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, 225 Changhai
Road, Shanghai 0086-200438, China. Tel: + 86 21 8187 5001. Fax: + 86 21 6556 2400. E-mail: qiufujian@
sina.com
Introduction
Primary liver cancer (PLC) is one of the most common cancers
worldwide, especially in China. Hepatic resection remains the best
therapeutic strategy for PLC at present and can significantly
improve both overall survival (OS) and disease-free survival
(DFS) in these patients. However, incidences of post-hepatectomy
complications range from 10% to as high as 50%,1–4 and inci-
dences of postoperative intra-abdominal haemorrhage range
between 1% and 5%.4–8 Haemorrhage is one of the leading causes
of morbidity and mortality after hepatectomy. Few studies have
investigated the outcomes of post-hepatectomy haemorrhage.
During a recent 10-year period, over 30 000 hepatectomies for
PLC were performed at the present institution. This report exam-
ines patients submitted to a second laparotomy for haemorrhage
following hepatectomy at the study institution. Risk factors for
post-hepatectomy complications, the management of postopera-
tive complications, and survival data were reviewed and analysed.
Materials and methods
Patients and preoperative management
A total of 32 856 hepatectomies for PLC were performed between
January 2001 and December 2010 at the Eastern Hepatobiliary
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Surgery Hospital in Shanghai, China. Among the patients repre-
sented by these hepatectomies, 77 (0.2%) required re-laparotomy
for postoperative intra-abdominal haemorrhage. Clinical data
were collected on age, gender, liver and kidney function tests,
coagulation function, alpha-fetoprotein (AFP), hepatitis,
reoperation time, type of hepatectomy, operative data, postopera-
tive complications, and length of postoperative hospital stay. All of
the 77 patients were assessed by B-ultrasound, computed tomog-
raphy or magnetic resonance imaging prior to hepatectomy. Liver
function was evaluated according to serum bilirubin, Child–Pugh
class9 and coagulation function. Hepatectomies involving more
than two Couinaud segments were designated as major
hepatectomies and all other resections were considered minor
hepatectomies.10
Surgical procedures
An intermittent Pringle manoeuvre was used at the time of liver
transection with a modified total hepatic vascular exclusion
(THVE) procedure if necessary.11 Hepatectomy was performed
using the Kelly clamp-crush method and the finger-fracture tech-
nique. A venovenous bypass was not used in any case. Any bleed-
ing or open bile ducts on the remaining side of the parenchyma
were directly sutured. The cut surface was managed at the discre-
tion of the operating surgeon with full-thickness compression
sutures, a pedicle of the greater omentum and/or fibrin glue.12
Before the abdomen was closed, a drain was routinely placed
below the right diaphragm and continuous low suction was
applied postoperatively. The total bilirubin level in the drainage
fluid was measured postoperatively and bile leakage was diag-
nosed when the bilirubin level in drainage fluid exceeded
30 μmol/l and persisted for > 7 days. The tubes were removed
when the amount of discharge decreased to < 10 ml per day. Post-
operative haemorrhage was considered when bleeding from the
drainage tubes exceeded 100 ml/h.
Laparotomic exploration procedures (second surgery)
Laparotomy was performed through the original incision and
blood clots were evacuated. For haemorrhage involving the cut
surface of the liver, compression sutures of the residual liver were
opened to identify the source of bleeding. For oozing sites, absorb-
able haemostatic gauze was applied. A drain was placed below the
right diaphragm again. All patients were admitted to the intensive
care unit and were observed continuously for changes in the
abdominal drain and/or vital signs.
Postoperative assessment
Surgical postoperative complications in patients who were
returned to the operating room (OR) included ascites, pleural
effusions, hyperbilirubinaemia, bile leakage, abdominal abscesses,
renal failure and wound infections. The presence of hyper-
bilirubinaemia referred to a maximum postoperative serum total
bilirubin of > 100 μmol/l,13,14 for which aggressive steroid
hormone therapy, liver protection drugs and fresh plasma replace-
ment therapy were administered. Shock was defined as a mean
arterial pressure (MAP) of < 60 mmHg. Patients with postopera-
tive ascites or pleural effusion were defined as requiring diuretic
agents or paracentesis/pleuracentesis. Death within 90 days
after hepatectomy was defined as death from postoperative
complications.15
Statistical methods
Statistical analysis was performed using spss Version 13.0 (SPSS,
Inc., Chicago, IL, USA). Continuous variables were expressed as
the median and range, and comparative variables were compared
using the Mann–WhitneyU-test. Differences were considered sig-
nificant at a P-value of < 0.05. Overall and disease-free survival
were evaluated using the Kaplan–Meier method.
Results
Patient data
Preoperative data are shown in Table 1.
Of the 32 856 patients examined, 77 (0.2%) patients required to
be returned to the OR for haemorrhage. This group included 11
female and 66 male patients with a median age of 52 years (range:
16–79 years). Of the 77 patients, 62 (80.5%) showed positive find-
ings for HBsAg [hepatitis B virus (HBV) surface antigen], 41
(53.2%) were positive for HBV DNA, and one (1.3%) was positive
for hepatitis C virus (HCV). Primary liver cancer in these patients
was classified as hepatocellular carcinoma in 69 (89.6%) patients,
cholangiocarcinoma in five (6.5%) patients, hepatic sarcoma in
two (2.6%) patients, and clear cell carcinoma of the liver in one
(1.3%) patient.
Hepatectomy outcomes
Themedian operative time for the original hepatectomy, including
in the 11 patients in whom inflow occlusion was not used and the
66 in whom inflow occlusion (Pringle technique) was applied, was
190 min (range: 95–226 min). The median occlusion time was
19 min (range: 5–58 min). Single occlusions were required in 47
patients and two occlusions were required in 19, including six
patients in whom both a Pringle occlusion and THVE were used.
Median intraoperative blood loss was 600 ml (range: 50–5600 ml);
there was no significant difference in mean ± standard deviation
(SD) intraoperative blood loss between patients with and
without cirrhosis (1025 ± 1138 ml and 811 ± 870 ml, respectively;
P = 0.409). Intraoperative transfusions were administered in 53
(68.8%) patients. Thirty-five patients received transfusions of red
blood cells (RBC) (median: 695 ml, range: 400–5000 ml) and 36
received transfusions of fresh frozen plasma (FFP) (median:
400 ml, range: 200–1800 ml). Minor hepatectomies were per-
formed in 40 (51.9%) patients and major hepatectomies were
performed in 37 (48.1%) patients (Table 2); there were no signifi-
cant differences between patients undergoing major and minor
hepatectomy, respectively.
Patients with large tumours (diameter > 10 cm) were more
likely to develop intraoperative haemorrhage than those with
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smaller tumours (mean ± SD: 1469 ± 1252 ml and 586 ± 651 ml,
respectively; P < 0.01), and required greater intraoperative trans-
fusion volumes (mean ± SD: 1261 ± 1500 ml and 322 ± 632 ml,
respectively; P < 0.01), and longer Pringle occlusion time
(mean ± SD: 29.5 ± 19.1 min and 11.7 ± 12.1 min, respectively;
P < 0.01).
Outcomes of the return to the OR
A total of 77 patients were returned to the OR for suspected
bleeding. The median interval between the initial hepatectomy
and return to the OR was 23 h (range: 1 h to 11 days). Return
occurred within 24 h after hepatectomy in 64 (83.1%) patients
and within 8 h after hepatectomy in 37 (48.1%) patients. The
most common clinical presentations were haemorrhage into the
drain (67.5%), shock (37.7%), and a declining haemoglobin (Hb)
level (48.1%). Drain output exceeded 100 ml/h in 52 patients.
Signs of shock (MAP of < 60 mmHg) were not significantly
improved by increasing fluid replacement and led to
re-exploration in 29 patients. The median decline in Hb after
hepatectomy was 30 g/l (range: 1–74 g/l) in 37 patients and 60 g/l
in six patients.
At the time of re-exploration, median occlusion time was
12 min (range: 6–25 min) in four patients in whom a Pringle
occlusion technique was used. Median blood loss at
re-exploration (excluding evacuated clots) was 245 ml (range:
10–6000 ml). Transfusions were required in 73 (94.8%) of the 77
patients, and included RBC (median: 1800 ml, range: 400–
5700 ml) and FFP (median: 800 ml, range: 200–2500 ml).
Arterial haemorrhage, haemorrhage from portal branches,
haemorrhage from hepatic veins or branches of the inferior vena
cava, and oozing of blood were observed during surgery in 14
(18.2%), eight (10.4%), nine (11.7%) and 46 (59.7%) [including
37 (48.1%) patients in whom blood oozing occurred on the cut
surface of the liver] patients, respectively. The most common site
of intra-abdominal haemorrhage was the cut surface of the liver
(n = 51, 66.2%), followed by the perihepatic ligaments (n = 19,
24.7%), the splenic fossa (n = 7, 9.1%), the diaphragm (n = 6,
7.8%), the retroperitonium (n = 6, 7.8%), the right adrenal gland
(n = 3, 3.9%) and the gallbladder bed (n = 2, 2.6%) (Table 3).
Table 1 Characteristics of patients requiring a return to the operating
room after hepatectomy as a result of haemorrhage
Patients Variable data
Gender (female/male), n 11/66
Age, years, median (range) 52(16–79)
Underlying liver, n (%)
Normal 12 (15.6%)
Fibrosis 24 (31.2%)
Cirrhosis 41 (53.2%)
Child–Pugh class, A/B/C, n 48/29/0
Preoperative laboratory results,
median (range)
ALT, IU/l, median (range) 45.3 (17.2–249.3)
AST, IU/l, median (range) 59.4 (22.6–275.6)
Total bilirubin, μmol/l, median (range) 16.8 (6.6–37.6)
Albumin, g/l, median (range) 39.7 (29.5–52.8)
Prothrombin time, s, median (range) 12.6 (9.6–19.2)
Haemoglobin, g/l, median (range) 136 (79–180)
Platelet count, ×109/l, median (range) 133 (68–397)
AFP, ng/l, (0–40/40–400/> 400 ng/l), n 29/16/32
HBsAg, (positive/negative), n 62/15
HCV, (positive/negative), n 1/76
Liver tumour, n
Tumour differentiation (good/moderate) 17/60
Tumour size (< 10 cm/≥ 10 cm) 44/33
Tumour capsule (−/+) 47/30
Tumour number (single/multiple) 72/5
Satellite tumours (−/+) 67/10
Macrovascular invasion (−/+) 67/10
Microvascular invasion (−/+) 50/27
ALT, alanine aminotransferase (normal range: 11–50 IU/l); AST, aspartate
aminotransferase (normal range: 14–50 IU/l); total bilirubin (normal
range: 2–17 μmol/l); albumin (normal range: 35–50 g/l); prothrombin time
(normal range: 10–14 s); AFP, alpha-fetoprotein; HBsAg, hepatitis B virus
surface antigen; HCV, hepatitis C virus.
Table 2 Types of liver resection in patients with primary liver cancer
who required a return to the operating room as a result of
haemorrhagea
Type of resection Patients, n (%)
Major hepatectomy 37 (48.1%)
Extended right hemi-hepatectomy 9 (11.7%)
Extended left hemi-hepatectomy 1 (1.3%)
Right hemi-hepatectomy 15 (19.5%)
Left hemi-hepatectomy 6 (7.8%)
Media trisegmentectomy 6 (7.8%)
Minor hepatectomy 40 (51.9%)
Left lateral sectionectomy (segments II, III) 4 (5.2%)
Right bisegmentectomy 14 (18.2%)
Left segmentectomy 2 (2.6%)
Right segmentectomy 18 (23.4%)
Atypical resection 2 (2.6%)
Associated resections 37 (48.1%)
Cholecystectomy 25 (32.5%)
Splenectomy 10 (13.0%)
Portal vein embolectomy 5 (6.59%)
Choledochojejunostomy 1 (1.3%)
a37 patients underwent associated surgeries including: cholecystectomy
(n = 21); splenectomy (n = 8); portal vein embolectomy (n = 4); cholecys-
tectomy and splenectomy (n = 2); portal vein embolectomy and chol-
ecystectomy (n = 1), and choledochojejunostomy and cholecystectomy
(n = 1).
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Hepatic outflow obstruction occurred in two of the 77 patients,
presenting as liver swelling and congestion, and was relieved by
the undoing of full-thickness compression sutures. Early haemor-
rhage (< 24 h) was most likely to occur in the form of venous
bleeding or oozing from the cut surface of the liver (Tables 3,4;
Fig. 1). However, there were no significant differences between
patients experiencing early and late haemorrhage, respectively, in
preoperative Child–Pugh class, postoperative international nor-
malized ratio (INR) or time for Pringle procedure.
Other postoperative complications
Of the 77 patients submitted to re-exploration, 42 (54.5%) devel-
oped other postoperative complications and seven (9.1%) died of
postoperative complications. The most common postoperative
complications were ascites (n = 30), hyperbilirubinaemia
(n = 11), pleural effusion (n = 10), and intra-abdominal infection
(n = 4). Two patients died during the hospital stay of liver dys-
function and septicaemia, respectively. No patient required to be
returned to the OR a third time. Rates of 5-year OS and DFS in the
77 patients were 22.1% and 3.9%, respectively (Fig. 2).
Discussion
As a result of technical advances in surgery, anaesthesia and
perioperative management, the incidence of mortality in patients
submitted to hepatectomy has decreased from 20% to < 5% over
the past 30 years.16 However, post-hepatectomy complication rates
remain between 38% and 47%.3,4,17 The most common postopera-
tive complications following hepatectomy include pneumonia,
ascites, hepatic dysfunction, intra-abdominal haematoceles, and
abscesses. Some researchers17,18 have concluded that the occur-
rence of post-hepatectomy complications is related to Child–Pugh
Table 3 Sites of intra-abdominal haemorrhage
Artery, n Portal vein, n Hepatic vein, n Oozing, n P-value
Liver remnant facet + 4 6 4 37 0.002
− 10 2 5 9
Diaphragm + 0 0 2 4 0.211
− 14 8 7 42
Perihepatic ligamenta + 7 1 2 9 0.105
− 7 7 7 37
Gallbladder bed + 0 0 0 2 0.709
− 14 8 9 44
Splenic fossa + 1 1 0 5 0.740
− 13 7 9 41
Retroperitoneum + 1 0 1 4 0.832
− 13 8 8 42
Right adrenal gland + 2 0 1 0 0.058
− 12 8 8 46
aThe perihepatic ligament category includes the falciform ligament, left and right triangular ligament, hepatogastric ligament and coronary ligament.
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Figure 1 Time between the initial hepatectomy and return to the operating room
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class, time of portal occlusion, duration of operation and extent of
hepatectomy. Other authors3 believe the occurrence of post-
hepatectomy complications to be related to the preoperative plate-
let count, a surrogate for portal pressure and/or intraoperative
transfusion requirements. It is felt the immunosuppressive effects
of transfusion may yield increased complications19 and these
effects have been shown to impact overall survival.20,21 Kusano
et al.22 reported that Child–Pugh class B status and intraoperative
blood loss of > 1200 ml are independent predictive factors of
post-hepatectomy complications. Although a recent report6 sug-
gested that post-hepatectomy intra-abdominal haemorrhage
should be classified for the purpose of statistical analysis, few
studies have focused on its causes, and the subject of return to the
OR is rarely addressed in the literature.
In the present series, the most common clinical signs of haem-
orrhage in patients who were returned to the OR after hepatec-
tomy were blood in the drain, postoperative shock and a decrease
in serum haemoglobin. Although drainage rates exceeded
100 ml/h during the early period after hepatectomy in some
patients, laparotomy was not performed for the reasons of intra-
abdominal effusion, a progressive decrease in drainage rate or a
gradual lightening in the colour of the drainage fluid. In patients
in whom drainage rates do not decrease but instead increase, Hb
in the abdominal fluid should bemeasured and the Hb ratio in the
abdominal fluid and blood should be compared. Immediate
laparotomy is necessary in patients in whom the abdominal
fluid : blood Hb ratio is > 0.5.
Drain output is not the only indicator of postoperative haem-
orrhage. In the event that postoperative drainage is small, but the
patient is hypotensive and/or tachycardic, follow-up Hb and
bedside B-ultrasound are necessary.
The timing of return to the OR must be based on the clinical
judgement of the surgeon. The results of the present study showed
that postoperative haemorrhage often occurred within 24 h after
hepatectomy. However, the timing of reoperation should be con-
sidered in the context of a comprehensive assessment of the actual
clinical situation, including the rate and colour of drain output,
the abdominal fluid : blood Hb ratio, and vital signs. Haemoglo-
bin fluctuation is an important factor in decision making in the
post-hepatectomy patient. In the occasional patient in whom
re-laparotomy does not yield significant haemorrhage, a second
laparotomy is recommended as long as the patient’s condition
permits this in order to avoid the occurrence of more severe
complications. Early haemorrhage (at < 24 h) is more likely to
occur as venous bleeding or oozing from facets of the liver
remnant, which suggests that early postoperative haemorrhage is
related to inappropriate intraoperative haemostasis and/or poor
postoperative coagulation. Timely clotting factor replacement,
and the meticulous observation of vital signs, drain output and
Hb changes in the drainage fluid are important in the manage-
ment of postoperative haemorrhage.
In addition to careful intraoperative manipulation, the mode of
remnant liver management is also important for the prevention of
postoperative intra-abdominal haemorrhage. As the liver is cir-
rhotic in most liver cancer patients, blood oozing is likely to occur
in the liver remnant and excessive sutures cannot prevent this
from happening. Haemostatic agents and clotting factors, or local
packing with gauze, can potentially assist in these cases.
Intraoperative blood loss and transfusion have proved to have
significant impact on short- and longterm postoperative survival
in hepatectomy patients. The control of intraoperative haemor-
rhage has long been a major concern.23,24 Massive perioperative
blood loss may adversely affect longterm postoperative OS and
DFS, both of which may be shortened by intraoperative blood loss
of > 1200 ml.22 Intraoperative hepatic outflow occlusion and half-
hepatic inflow occlusion can improve intraoperative haemorrhage
markedly,11 but are not effective for controlling retroperitoneal
haemorrhage.
In the present series, hepatic outflow occlusion led to clinical
symptoms of intra-abdominal haemorrhage in two patients, pre-
senting as hypovolaemia, persistent postoperative hypotension
and increased abdominal drainage, but Hb was not significantly
decreased in these patients in comparison with that in patients in
whom intra-abdominal haemorrhage occurred after other types
of hepatectomy.
In summary, haemorrhage that requires the patient to be
returned to the OR is most likely to occur within 24 h after hepa-
tectomy. The best time for a return to the OR is within 4 h
Table 4 Relationship between postoperative intra-abdominal haem-
orrhage and sites of haemorrhage following hepatectomy
Early haemorrhage P-value
> 24 h ≤ 24 h
Sites of haemorrhage Patients, n Patients, n
Liver remnant facet − 8 18 0.027
+ 5 46
Diaphragm − 11 60 0.226
+ 2 4
Ligament − 7 51 0.075
+ 6 13
Retroperitonium − 13 58 0.582
+ 0 6
Gallbladder bed − 12 63 0.311
+ 1 1
Splenic fossa − 10 60 0.089
+ 3 4
Right adrenal gland − 13 61 0.570
+ 0 3
Nature of haemorrhage
Artery 6 8 0.018
Portal vein 2 6
Hepatic vein 0 9
Oozing 5 41
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following hepatectomy because an early return implies fewer post-
operative complications and improved survival. Drain output,
haemodynamics and serum haemoglobin can serve as valuable
cues to guide a prompt return to the OR.
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